Johnson & Johnson pauses COVID vaccine trial over sick participant

Johnson & Johnson pauses COVID vaccine trial over sick participant

CBS News

Published

The New Jersey-based pharmaceuticals giant is the latest to halt a major coronavirus vaccine trial over a single unexplained illness.

Full Article